- Home
- IMAB vs LODE Comparison
IMAB vs LODE Comparison
Compare IMAB & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- LODE
- Stock Information
- Founded
- IMAB 2014
- LODE 2008
- Country
- IMAB United States
- LODE United States
- Employees
- IMAB N/A
- LODE N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- LODE Major Chemicals
- Sector
- IMAB Health Care
- LODE Industrials
- Exchange
- IMAB Nasdaq
- LODE Nasdaq
- Market Cap
- IMAB 83.8M
- LODE 79.6M
- IPO Year
- IMAB 2020
- LODE N/A
- Fundamental
- Price
- IMAB $1.07
- LODE $0.30
- Analyst Decision
- IMAB Strong Buy
- LODE Buy
- Analyst Count
- IMAB 3
- LODE 1
- Target Price
- IMAB $8.00
- LODE $2.60
- AVG Volume (30 Days)
- IMAB 682.1K
- LODE 16.7M
- Earning Date
- IMAB 03-13-2025
- LODE 02-26-2025
- Dividend Yield
- IMAB N/A
- LODE N/A
- EPS Growth
- IMAB N/A
- LODE N/A
- EPS
- IMAB N/A
- LODE N/A
- Revenue
- IMAB $3,313,984.00
- LODE $1,864,811.00
- Revenue This Year
- IMAB N/A
- LODE $69.41
- Revenue Next Year
- IMAB N/A
- LODE $56.83
- P/E Ratio
- IMAB N/A
- LODE N/A
- Revenue Growth
- IMAB N/A
- LODE 117.46
- 52 Week Low
- IMAB $0.84
- LODE $0.13
- 52 Week High
- IMAB $2.08
- LODE $1.01
- Technical
- Relative Strength Index (RSI)
- IMAB 55.17
- LODE 39.65
- Support Level
- IMAB $1.00
- LODE $0.26
- Resistance Level
- IMAB $1.20
- LODE $0.54
- Average True Range (ATR)
- IMAB 0.12
- LODE 0.12
- MACD
- IMAB 0.02
- LODE -0.04
- Stochastic Oscillator
- IMAB 40.97
- LODE 6.49
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About LODE Comstock Inc.
Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.